Mitophagy, Inflammasomes and Their Interaction in Kidney Diseases: A Comprehensive Review of Experimental Studies

References

• Yang J, Xiao L, Sun L. Research progress of mitochondria, endoplasmic reticulum and their tight junctions in the pathogenesis of diabetic nephropathy. Antioxidants. 2021;101(10):750–754.
   Google Scholar
• Emma F, Montini G, Parikh SM, et al. Mitochondrial dysfunction in inherited renal disease and acute kidney injury. Nat Rev Nephrol. 2016;12(5):267–280.
   PubMed Web of Science ®Google Scholar
• Maekawa H, Inoue T, Ouchi H, et al. Mitochondrial damage causes inflammation via cGAS-STING signaling in acute kidney injury. Cell Rep. 2019;29(5):1261–1273. doi:10.1016/j.celrep.2019.09.050
   PubMed Web of Science ®Google Scholar
• Granata S, Dalla GA, Tomei P, et al. Mitochondria: a new therapeutic target in chronic kidney disease. Nutr Metab. 2015;12:49.
   Google Scholar
• Parikh SM, Yang Y, He L, et al. Mitochondrial function and disturbances in the septic kidney. Semin Nephrol. 2015;35(1):108–119. doi:10.1016/j.semnephrol.2015.01.011
   PubMed Web of Science ®Google Scholar
• Ahmad AA, Draves SO, Rosca M. Mitochondria in diabetic kidney disease. Cells. 2021;10(11):11. doi:10.3390/cells10112945
   Google Scholar
• Dai W, Lu H, Chen Y, et al. The loss of mitochondrial quality control in diabetic kidney disease. Front Cell Dev Biol. 2021;9:706832. doi:10.3389/fcell.2021.706832
   PubMed Web of Science ®Google Scholar
• Tang C, Cai J, Yin X-M, et al. Mitochondrial quality control in kidney injury and repair. Nat Rev Nephrol. 2021;17(5):299–318. doi:10.1038/s41581-020-00369-0
   PubMed Web of Science ®Google Scholar
• Panigrahi DP, Praharaj PP, Bhol CS, et al. The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics. Semin Cancer Biol. 2020;66:45–58. doi:10.1016/j.semcancer.2019.07.015
   PubMed Web of Science ®Google Scholar
• Kesharwani R, Sarmah D, Kaur H, et al. Interplay between mitophagy and inflammasomes in neurological disorders. ACS Chem Neurosci. 2019;10(5):2195–2208. doi:10.1021/acschemneuro.9b00117
   PubMedGoogle Scholar
• Yuk JM, Silwal P, Jo EK. Inflammasome and mitophagy connection in health and disease. Int J Mol Sci. 2020;21(13):4714. doi:10.3390/ijms21134714
   PubMedGoogle Scholar
• Mcbride HM, Neuspiel M, Wasiak S. Mitochondria: more than just a powerhouse. Curr Biol. 2006;16(14):R551–R560. doi:10.1016/j.cub.2006.06.054
   PubMed Web of Science ®Google Scholar
• Guan X, Qian Y, Shen Y, et al. Autophagy protects renal tubular cells against ischemia / reperfusion injury in a time-dependent manner. Cell Physiol Biochem. 2015;36(1):285–298. doi:10.1159/000374071
   PubMedGoogle Scholar
• Palikaras K, Lionaki E, Tavernarakis N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol. 2018;20(9):1013–1022. doi:10.1038/s41556-018-0176-2
   PubMed Web of Science ®Google Scholar
• Hamacher-Brady A, Brady NR. Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy. Cell Mol Life Sci. 2016;73(4):775–795. doi:10.1007/s00018-015-2087-8
   PubMed Web of Science ®Google Scholar
• Doblado L, Lueck C, Rey C, et al. Mitophagy in human diseases. Int J Mol Sci. 2021;22(8):8. doi:10.3390/ijms22083903
   Google Scholar
• Chan NC, Salazar AM, Pham AH, et al. Broad activation of the ubiquitin-proteasome system by parkin is critical for mitophagy. Hum Mol Genet. 2011;20(9):1726–1737. doi:10.1093/hmg/ddr048
   PubMed Web of Science ®Google Scholar
• Matsuda N. Phospho-ubiquitin: upending the PINK-Parkin-ubiquitin cascade. J Biochem. 2016;159(4):379–385. doi:10.1093/jb/mvv125
   PubMed Web of Science ®Google Scholar
• Zachari M, Ktistakis NT. Mammalian mitophagosome formation: a focus on the early signals and steps. Front Cell Dev Biol. 2020;8:171. doi:10.3389/fcell.2020.00171
   PubMed Web of Science ®Google Scholar
• Bhatia D, Choi ME. The emerging role of mitophagy in kidney diseases. J Life Sci. 2019;1(3):13–22.
   Google Scholar
• Zuo Z, Jing K, Wu H, et al. Mechanisms and functions of mitophagy and potential roles in renal disease. Front Physiol. 2020;11:935. doi:10.3389/fphys.2020.00935
   PubMed Web of Science ®Google Scholar
• Lin Q, Ni Z. 线粒体自噬在肾脏疾病中的研究进展 [Research advances in mitophagy in kidney disease]. Chin J Blood Purif. 2019;18(03):197–200. Chinese.
   Google Scholar
• Choi GE, Lee HJ, Chae CW, et al. BNIP3L/NIX-mediated mitophagy protects against glucocorticoid-induced synapse defects. Nat Commun. 2021;12(1):487. doi:10.1038/s41467-020-20679-y
   PubMed Web of Science ®Google Scholar
• Xu Y, Shen J, Ran Z. Emerging views of mitophagy in immunity and autoimmune diseases. Autophagy. 2020;16(1):3–17. doi:10.1080/15548627.2019.1603547
   PubMed Web of Science ®Google Scholar
• Wu W, Tian W, Hu Z, et al. ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy. EMBO Rep. 2014;15(5):566–575. doi:10.1002/embr.201438501
   PubMed Web of Science ®Google Scholar
• Killackey SA, Philpott DJ, Girardin SE. Mitophagy pathways in health and disease. J Cell Biol. 2020;219(11). doi:10.1083/jcb.202004029
   PubMed Web of Science ®Google Scholar
• Bhujabal Z, Birgisdottir AB, Sjottem E, et al. FKBP8 recruits LC3A to mediate Parkin-independent mitophagy. EMBO Rep. 2017;18(6):947–961. doi:10.15252/embr.201643147
   PubMed Web of Science ®Google Scholar
• Yan C, Gong L, Chen L, et al. PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis. Autophagy. 2020;16(3):419–434. doi:10.1080/15548627.2019.1628520
   PubMed Web of Science ®Google Scholar
• Kagan VE, Jiang J, Huang Z, et al. NDPK-D (NM23-H4)-mediated externalization of cardiolipin enables elimination of depolarized mitochondria by mitophagy. Cell Death Differ. 2016;23(7):1140–1151. doi:10.1038/cdd.2015.160
   PubMed Web of Science ®Google Scholar
• Sun N, Yun J, Liu J, et al. Measuring in vivo mitophagy. Mol Cell. 2015;60(4):685–696. doi:10.1016/j.molcel.2015.10.009
   PubMed Web of Science ®Google Scholar
• Bakula D, Scheibye-Knudsen M. MitophAging: mitophagy in aging and disease. Front Cell Dev Biol. 2020;8:239. doi:10.3389/fcell.2020.00239
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang M, Zhu W, et al. Succinate accumulation induces mitochondrial reactive oxygen species generation and promotes status epilepticus in the kainic acid rat model. Redox Biol. 2020;28:101365. doi:10.1016/j.redox.2019.101365
   PubMed Web of Science ®Google Scholar
• Bernardini JP, Lazarou M, Dewson G. Parkin and mitophagy in cancer. Oncogene. 2017;36(10):1315–1327. doi:10.1038/onc.2016.302
   PubMed Web of Science ®Google Scholar
• Zhou H, He L, Xu G, et al. Mitophagy in cardiovascular disease. Clin Chim Acta. 2020;507:210–218. doi:10.1016/j.cca.2020.04.033
   PubMed Web of Science ®Google Scholar
• Zhao C, Chen Z, Xu X, et al. Pink1/Parkin-mediated mitophagy play a protective role in cisplatin induced renal tubular epithelial cells injury. Exp Cell Res. 2017;350(2):390–397. doi:10.1016/j.yexcr.2016.12.015
   PubMed Web of Science ®Google Scholar
• Tang C, Han H, Yan M, et al. PINK1-PRKN/PARK2 pathway of mitophagy is activated to protect against renal ischemia-reperfusion injury. Autophagy. 2018;14(5):880–897. doi:10.1080/15548627.2017.1405880
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu J, Liu Z, et al. The PINK1/PARK2/optineurin pathway of mitophagy is activated for protection in septic acute kidney injury. Redox Biol. 2021;38:101767. doi:10.1016/j.redox.2020.101767
   PubMed Web of Science ®Google Scholar
• Fu ZJ, Wang ZY, Xu L, et al. HIF-1alpha-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia/reperfusion injury. Redox Biol. 2020;36:101671. doi:10.1016/j.redox.2020.101671
   PubMed Web of Science ®Google Scholar
• Humphreys BD. Mechanisms of renal fibrosis. Annu Rev Physiol. 2018;80:309–326. doi:10.1146/annurev-physiol-022516-034227
   PubMed Web of Science ®Google Scholar
• Aparicio-Trejo OE, Tapia E, Molina-Jijon E, et al. Curcumin prevents mitochondrial dynamics disturbances in early 5/6 nephrectomy: relation to oxidative stress and mitochondrial bioenergetics. Biofactors. 2017;43(2):293–310. doi:10.1002/biof.1338
   PubMedGoogle Scholar
• Ma N, Wei Z, Hu J, et al. Farrerol ameliorated cisplatin-induced chronic kidney disease through mitophagy induction via Nrf2/PINK1 pathway. Front Pharmacol. 2021;12:768700. doi:10.3389/fphar.2021.768700
   PubMed Web of Science ®Google Scholar
• Ding XQ, Jian TY, Gai YN, et al. Chicoric acid attenuated renal tubular injury in HFD-induced chronic kidney disease mice through the promotion of mitophagy via the Nrf2/PINK/Parkin pathway. J Agric Food Chem. 2022;70(9):2923–2935. doi:10.1021/acs.jafc.1c07795
   PubMed Web of Science ®Google Scholar
• Jin L, Yu B, Liu G, et al. Mitophagy induced by UMI-77 preserves mitochondrial fitness in renal tubular epithelial cells and alleviates renal fibrosis. FASEB J. 2022;36(6):e22342. doi:10.1096/fj.202200199RR
   PubMed Web of Science ®Google Scholar
• Liu B, Cao Y, Wang D, et al. Zhen-Wu-Tang induced mitophagy to protect mitochondrial function in chronic glomerulonephritis via PI3K/AKT/mTOR and AMPK pathways. Front Pharmacol. 2021;12:777670. doi:10.3389/fphar.2021.777670
   PubMedGoogle Scholar
• Wu X, Li J, Wang S, et al. 2-undecanone protects against fine particle-induced kidney inflammation via inducing mitophagy. J Agric Food Chem. 2021;69(17):5206–5215. doi:10.1021/acs.jafc.1c01305
   PubMedGoogle Scholar
• Yi X, Guo T, Zhang M, et al. 线粒体自噬紊乱在糖尿病肾病发病机制中的作用研究进展 [Research progress in role of mitophagy dysfunction in pathogenesis of diabetic nephropathy]. Chin J Pharmacol Toxicol. 2019;33(11):994–999. Chinese.
   Google Scholar
• Smith MA, Covington MD, Schnellmann RG. Loss of calpain 10 causes mitochondrial dysfunction during chronic hyperglycemia. Arch Biochem Biophys. 2012;523(2):161–168. doi:10.1016/j.abb.2012.04.020
   PubMedGoogle Scholar
• Higgins GC, Coughlan MT. Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy? Br J Pharmacol. 2014;171(8):1917–1942. doi:10.1111/bph.12503
   PubMed Web of Science ®Google Scholar
• Xiao L, Xu X, Zhang F, et al. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1. Redox Biol. 2017;11:297–311. doi:10.1016/j.redox.2016.12.022
   PubMed Web of Science ®Google Scholar
• Yu L, Wang Y, Guo YH, et al. HIF-1alpha alleviates high-glucose-induced renal tubular cell injury by promoting Parkin/PINK1-mediated mitophagy. Front Med. 2021;8:803874. doi:10.3389/fmed.2021.803874
   Web of Science ®Google Scholar
• Yi X, Yan W, Guo T, et al. Erythropoietin mitigates diabetic nephropathy by restoring PINK1/Parkin-mediated mitophagy. Front Pharmacol. 2022;13:883057. doi:10.3389/fphar.2022.883057
   PubMedGoogle Scholar
• Liu L, Bai F, Song H, et al. Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy. Redox Biol. 2022;50:102260. doi:10.1016/j.redox.2022.102260
   PubMed Web of Science ®Google Scholar
• Zheng T, Wang HY, Chen Y, et al. Src activation aggravates podocyte injury in diabetic nephropathy via suppression of FUNDC1-mediated mitophagy. Front Pharmacol. 2022;13:897046. doi:10.3389/fphar.2022.897046
   PubMed Web of Science ®Google Scholar
• Song YM, Lee WK, Lee YH, et al. Metformin restores Parkin-mediated mitophagy, suppressed by cytosolic p53. Int J Mol Sci. 2016;17(1):122. doi:10.3390/ijms17010122
   PubMedGoogle Scholar
• Sun J, Zhu H, Wang X, et al. CoQ10 ameliorates mitochondrial dysfunction in diabetic nephropathy through mitophagy. J Endocrinol. 2019. doi:10.1530/JOE-18-0578
   Google Scholar
• Tian Y, Guo H, Miao X, et al. Nestin protects podocyte from injury in lupus nephritis by mitophagy and oxidative stress. Cell Death Dis. 2020;11(5):319. doi:10.1038/s41419-020-2547-4
   PubMed Web of Science ®Google Scholar
• Connor TM, Hoer S, Mallett A, et al. Mutations in mitochondrial DNA causing tubulointerstitial kidney disease. PLoS Genet. 2017;13(3):e1006620. doi:10.1371/journal.pgen.1006620
   PubMedGoogle Scholar
• Viering D, Schlingmann KP, Hureaux M, et al. Gitelman-like syndrome caused by pathogenic variants in mtDNA. J Am Soc Nephrol. 2022;33(2):305–325. doi:10.1681/ASN.2021050596
   PubMedGoogle Scholar
• Gkikas I, Palikaras K, Tavernarakis N. The role of mitophagy in innate immunity. Front Immunol. 2018;9:1283. doi:10.3389/fimmu.2018.01283
   PubMed Web of Science ®Google Scholar
• Gurung P, Lukens JR, Kanneganti TD. Mitochondria: diversity in the regulation of the NLRP3 inflammasome. Trends Mol Med. 2015;21(3):193–201. doi:10.1016/j.molmed.2014.11.008
   PubMed Web of Science ®Google Scholar
• Komada T, Muruve DA. The role of inflammasomes in kidney disease. Nat Rev Nephrol. 2019;15(8):501–520. doi:10.1038/s41581-019-0158-z
   PubMed Web of Science ®Google Scholar
• Zhang WJ, Chen SJ, Zhou SC, et al. Inflammasomes and fibrosis. Front Immunol. 2021;12:643149. doi:10.3389/fimmu.2021.643149
   PubMed Web of Science ®Google Scholar
• Chi K, Geng X, Liu C, et al. Research progress on the role of inflammasomes in kidney disease. Mediators Inflamm. 2020;2020:8032797. doi:10.1155/2020/8032797
   PubMedGoogle Scholar
• Wang X. NOD1,NOD2和NLRP3炎症小体与牙髓炎 [NOD1, NOD2 and NLRP3 inflammasome in pulpitis]. J Clin Pathol Res. 2017;37(04):849–854. Chinese.
   Google Scholar
• Corridoni D, Arseneau KO, Cifone MG, et al. The dual role of nod-like receptors in mucosal innate immunity and chronic intestinal inflammation. Front Immunol. 2014;5:317. doi:10.3389/fimmu.2014.00317
   PubMedGoogle Scholar
• Schmid-Burgk JL, Gaidt MM, Schmidt T, et al. Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells. Eur J Immunol. 2015;45(10):2911–2917. doi:10.1002/eji.201545523
   PubMedGoogle Scholar
• Cao X. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat Rev Immunol. 2016;16(1):35–50. doi:10.1038/nri.2015.8
   PubMed Web of Science ®Google Scholar
• Vigano E, Diamond CE, Spreafico R, et al. Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes. Nat Commun. 2015;6(1):8761. doi:10.1038/ncomms9761
   PubMedGoogle Scholar
• Kayagaki N, Warming S, Lamkanfi M, et al. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479(7371):117–121. doi:10.1038/nature10558
   PubMed Web of Science ®Google Scholar
• Tummers B, Mari L, Guy CS, et al. Caspase-8-dependent inflammatory responses are controlled by its adaptor, FADD, and necroptosis. Immunity. 2020;52(6):994–1006. doi:10.1016/j.immuni.2020.04.010
   PubMed Web of Science ®Google Scholar
• Martinon F, Petrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237–241. doi:10.1038/nature04516
   PubMed Web of Science ®Google Scholar
• Man SM. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat Rev Gastroenterol Hepatol. 2018;15(12):721–737. doi:10.1038/s41575-018-0054-1
   PubMed Web of Science ®Google Scholar
• Pinkerton JW, Kim RY, Robertson A, et al. Inflammasomes in the lung. Mol Immunol. 2017;86:44–55. doi:10.1016/j.molimm.2017.01.014
   PubMed Web of Science ®Google Scholar
• van Hout G, Bosch L. The inflammasomes in cardiovascular disease. Exp Suppl. 2018;108:9–40. doi:10.1007/978-3-319-89390-7_2
   PubMedGoogle Scholar
• Silvis M, Demkes EJ, Fiolet A, et al. Immunomodulation of the NLRP3 inflammasome in atherosclerosis, coronary artery disease, and acute myocardial infarction. J Cardiovasc Transl Res. 2021;14(1):23–34. doi:10.1007/s12265-020-10049-w
   PubMed Web of Science ®Google Scholar
• Pulskens WP, Butter LM, Teske GJ, et al. Nlrp3 prevents early renal interstitial edema and vascular permeability in unilateral ureteral obstruction. PLoS One. 2014;9(1):e85775. doi:10.1371/journal.pone.0085775
   PubMed Web of Science ®Google Scholar
• Correa-Costa M, Braga TT, Semedo P, et al. Pivotal role of toll-like receptors 2 and 4, its adaptor molecule MyD88, and inflammasome complex in experimental tubule-interstitial nephritis. PLoS One. 2011;6(12):e29004. doi:10.1371/journal.pone.0029004
   PubMed Web of Science ®Google Scholar
• Bakker PJ, Butter LM, Kors L, et al. Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation. Kidney Int. 2014;85(5):1112–1122. doi:10.1038/ki.2013.503
   PubMed Web of Science ®Google Scholar
• Zhang C, Boini KM, Xia M, et al. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension. 2012;60(1):154–162. doi:10.1161/HYPERTENSIONAHA.111.189688
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Ding G, Zhao M, et al. NLRP3 inflammasome mediates albumin-induced renal tubular injury through impaired mitochondrial function. J Biol Chem. 2014;289(36):25101–25111. doi:10.1074/jbc.M114.578260
   PubMed Web of Science ®Google Scholar
• Wen Y, Liu Y, Tang T, et al. NLRP3 inflammasome activation is involved in Ang II-induced kidney damage via mitochondrial dysfunction. Oncotarget. 2016;7(34):54290–54302. doi:10.18632/oncotarget.11091
   PubMedGoogle Scholar
• Shahzad K, Bock F, Dong W, et al. Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int. 2015;87(1):74–84. doi:10.1038/ki.2014.271
   PubMed Web of Science ®Google Scholar
• Huang G, Bao J, Shao X, et al. Inhibiting pannexin-1 alleviates sepsis-induced acute kidney injury via decreasing NLRP3 inflammasome activation and cell apoptosis. Life Sci. 2020;254:117791. doi:10.1016/j.lfs.2020.117791
   PubMed Web of Science ®Google Scholar
• Andersen K, Eltrich N, Lichtnekert J, et al. The NLRP3/ASC inflammasome promotes T-cell-dependent immune complex glomerulonephritis by canonical and noncanonical mechanisms. Kidney Int. 2014;86(5):965–978. doi:10.1038/ki.2014.161
   PubMedGoogle Scholar
• Wu D, Ai L, Sun Y, et al. Role of NLRP3 inflammasome in lupus nephritis and therapeutic targeting by phytochemicals. Front Pharmacol. 2021;12:621300. doi:10.3389/fphar.2021.621300
   PubMedGoogle Scholar
• Gong W, Mao S, Yu J, et al. NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mouse with 5/6 nephrectomy. Am J Physiol Renal Physiol. 2016;310(10):F1081–F1088. doi:10.1152/ajprenal.00534.2015
   PubMed Web of Science ®Google Scholar
• Chivero ET, Guo ML, Periyasamy P, et al. HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation. J Neurosci. 2017;37(13):3599–3609. doi:10.1523/JNEUROSCI.3045-16.2017
   PubMed Web of Science ®Google Scholar
• Mulay SR, Anders HJ. Crystal nephropathies: mechanisms of crystal-induced kidney injury. Nat Rev Nephrol. 2017;13(4):226–240. doi:10.1038/nrneph.2017.10
   PubMed Web of Science ®Google Scholar
• Prencipe G, Caiello I, Cherqui S, et al. Inflammasome activation by cystine crystals: implications for the pathogenesis of cystinosis. J Am Soc Nephrol. 2014;25(6):1163–1169. doi:10.1681/ASN.2013060653
   PubMedGoogle Scholar
• Sharma BR, Karki R, Kanneganti TD. Role of AIM2 inflammasome in inflammatory diseases, cancer and infection. Eur J Immunol. 2019;49(11):1998–2011. doi:10.1002/eji.201848070
   PubMed Web of Science ®Google Scholar
• Du L, Wang X, Chen S, et al. The AIM2 inflammasome: a novel biomarker and target in cardiovascular disease. Pharmacol Res. 2022;186:106533. doi:10.1016/j.phrs.2022.106533
   PubMed Web of Science ®Google Scholar
• Baatarjav C, Komada T, Karasawa T, et al. dsDNA-induced AIM2 pyroptosis halts aberrant inflammation during rhabdomyolysis-induced acute kidney injury. Cell Death Differ. 2022. doi:10.1038/s41418-022-01033-9
   PubMedGoogle Scholar
• Zhen J, Zhang L, Pan J, et al. AIM2 mediates inflammation-associated renal damage in hepatitis B virus-associated glomerulonephritis by regulating caspase-1, IL-1beta, and IL-18. Mediators Inflamm. 2014;2014:190860. doi:10.1155/2014/190860
   PubMedGoogle Scholar
• Komada T, Chung H, Lau A, et al. Macrophage uptake of necrotic cell DNA activates the AIM2 inflammasome to regulate a proinflammatory phenotype in CKD. J Am Soc Nephrol. 2018;29(4):1165–1181. doi:10.1681/ASN.2017080863
   PubMed Web of Science ®Google Scholar
• Majidpoor J, Khezri Z, Rostamzadeh P, et al. The expressions of NLRP1, NLRP3, and AIM2 inflammasome complexes in the contusive spinal cord injury rat model and their responses to hormonal therapy. Cell Tissue Res. 2020;381(3):397–410. doi:10.1007/s00441-020-03250-5
   PubMedGoogle Scholar
• Chung H, Komada T, Lau A, et al. AIM2 suppresses inflammation and epithelial cell proliferation during glomerulonephritis. J Immunol. 2021;207(11):2799–2812. doi:10.4049/jimmunol.2100483
   PubMedGoogle Scholar
• Franchon MTN, Ziroldo LJ, Duarte GL, et al. AIM2 as a putative target in acute kidney graft rejection. Front Immunol. 2022;13:839359. doi:10.3389/fimmu.2022.839359
   PubMedGoogle Scholar
• Yuan F, Kolb R, Pandey G, Li W, Sun L, Liu F, Sutterwala F S, Liu Y, Zhang W. (2016). Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy. PLoS One, 11(10), e0164135 10.1371/journal.pone.0164135
   PubMedGoogle Scholar
• Li Y, Yu W, Xiong H and Yuan F. (2022). Circ_0000181 regulates miR-667-5p/NLRC4 axis to promote pyroptosis progression in diabetic nephropathy. Sci Rep, 12(1), 10.1038/s41598-022-15607-7
   Google Scholar
• Wang Y, Gou R, Yu L, et al. Activation of the NLRC4 inflammasome in renal tubular epithelial cell injury in diabetic nephropathy. Exp Ther Med. 2021;22(2):814. doi:10.3892/etm.2021.10246
   PubMedGoogle Scholar
• Meissner TB, Li A, Biswas A, et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc Natl Acad Sci U S A. 2010;107(31):13794–13799. doi:10.1073/pnas.1008684107
   PubMed Web of Science ®Google Scholar
• Li Q, Wang Z, Zhang Y, et al. NLRC5 deficiency protects against acute kidney injury in mice by mediating carcinoembryonic antigen-related cell adhesion molecule 1 signaling. Kidney Int. 2018;94(3):551–566. doi:10.1016/j.kint.2018.02.031
   PubMed Web of Science ®Google Scholar
• Luan P, Zhuang J, Zou J, et al. NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation. FASEB J. 2018;32(2):1070–1084. doi:10.1096/fj.201700511RR
   PubMed Web of Science ®Google Scholar
• Soares J, Fernandes FP, Patente TA, et al. Gain-of-function variants in NLRP1 protect against the development of diabetic kidney disease: NLRP1 inflammasome role in metabolic stress sensing? Clin Immunol. 2018;187:46–49. doi:10.1016/j.clim.2017.10.003
   PubMedGoogle Scholar
• Valino-Rivas L, Cuarental L, Nunez G, et al. Loss of NLRP6 expression increases the severity of acute kidney injury. Nephrol Dial Transplant. 2020;35(4):587–598. doi:10.1093/ndt/gfz169
   PubMedGoogle Scholar
• Song L, Gao C, Xue T, et al. Characterization and expression analysis of mitochondrial localization molecule: NOD-like receptor X1 (Nlrx1) in mucosal tissues of turbot (Scophthalmus maximus) following bacterial challenge. Dev Comp Immunol. 2021;116:103944. doi:10.1016/j.dci.2020.103944
   PubMedGoogle Scholar
• Moore CB, Bergstralh DT, Duncan JA, et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature. 2008;451(7178):573–577. doi:10.1038/nature06501
   PubMedGoogle Scholar
• Stokman G, Kors L, Bakker PJ, et al. NLRX1 dampens oxidative stress and apoptosis in tissue injury via control of mitochondrial activity. J Exp Med. 2017;214(8):2405–2420. doi:10.1084/jem.20161031
   PubMedGoogle Scholar
• Gao Y, Dai X, Li Y, et al. Role of Parkin-mediated mitophagy in the protective effect of polydatin in sepsis-induced acute kidney injury. J Transl Med. 2020;18(1):114. doi:10.1186/s12967-020-02283-2
   PubMed Web of Science ®Google Scholar
• Lin Q, Li S, Jiang N, et al. PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation. Redox Biol. 2019;26:101254. doi:10.1016/j.redox.2019.101254
   PubMed Web of Science ®Google Scholar
• Lin Q, Li S, Jiang N, et al. Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy. Autophagy. 2021;17(10):2975–2990. doi:10.1080/15548627.2020.1848971
   PubMed Web of Science ®Google Scholar
• Yang S-K, Han Y-C, He J-R, et al. Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathway. Biomed Pharmacother. 2020;130:110521. doi:10.1016/j.biopha.2020.110521
   PubMed Web of Science ®Google Scholar
• Shen Y, Jin X, Chen W, et al. Interleukin-22 ameliorated Acetaminophen-induced kidney injury by inhibiting mitochondrial dysfunction and inflammatory responses. Appl Microbiol Biotechnol. 2020;104(13):5889–5898. doi:10.1007/s00253-020-10638-4
   PubMed Web of Science ®Google Scholar
• Liu D, Xu M, Ding LH, et al. Activation of the Nlrp3 inflammasome by mitochondrial reactive oxygen species: a novel mechanism of albumin-induced tubulointerstitial inflammation. Int J Biochem Cell Biol. 2014;57:7–19. doi:10.1016/j.biocel.2014.09.018
   PubMed Web of Science ®Google Scholar
• Ding W, Liu T, Bi X, et al. Mitochondria-targeted antioxidant mito-tempo protects against aldosterone-induced renal injury in vivo. Cell Physiol Biochem. 2017;44(2):741–750. doi:10.1159/000485287
   PubMedGoogle Scholar
• Zhang C, Song Y, Chen L, et al. Urolithin A attenuates hyperuricemic nephropathy in fructose-fed mice by impairing STING-NLRP3 axis-mediated inflammatory response via restoration of Parkin-dependent mitophagy. Front Pharmacol. 2022;13:907209. doi:10.3389/fphar.2022.907209
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang J, Xu W, et al. Prohibitin 2-mediated mitophagy attenuates renal tubular epithelial cells injury by regulating mitochondrial dysfunction and NLRP3 inflammasome activation. Am J Physiol Renal Physiol. 2019;316(2):F396–F407. doi:10.1152/ajprenal.00420.2018
   PubMedGoogle Scholar
• Liao X, Jiang Y, Dai Q, et al. Fluorofenidone attenuates renal fibrosis by inhibiting the mtROS-NLRP3 pathway in a murine model of folic acid nephropathy. Biochem Biophys Res Commun. 2021;534:694–701. doi:10.1016/j.bbrc.2020.11.017
   PubMedGoogle Scholar
• Hsu WH, Hua KF, Tuan LH, et al. Compound K inhibits priming and mitochondria-associated activating signals of NLRP3 inflammasome in renal tubulointerstitial lesions. Nephrol Dial Transplant. 2020;35(1):74–85. doi:10.1093/ndt/gfz073
   PubMedGoogle Scholar
• Han Y, Xu X, Tang C, et al. Reactive oxygen species promote tubular injury in diabetic nephropathy: the role of the mitochondrial ros-txnip-nlrp3 biological axis. Redox Biol. 2018;16:32–46. doi:10.1016/j.redox.2018.02.013
   PubMed Web of Science ®Google Scholar
• Lerner AG, Upton JP, Praveen PV, et al. IRE1alpha induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab. 2012;16(2):250–264. doi:10.1016/j.cmet.2012.07.007
   PubMed Web of Science ®Google Scholar
• Chen K, Feng L, Hu W, et al. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy. FASEB J. 2019;33(3):4571–4585. doi:10.1096/fj.201801749RRR
   PubMed Web of Science ®Google Scholar
• Hou Y, Wang Q, Han B, et al. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys. Cell Death Dis. 2021;12(6):523. doi:10.1038/s41419-021-03813-6
   PubMed Web of Science ®Google Scholar
• Ding X, Zhao H, Qiao C. Icariin protects podocytes from NLRP3 activation by Sesn2-induced mitophagy through the Keap1-Nrf2/HO-1 axis in diabetic nephropathy. Phytomedicine. 2022;99:154005. doi:10.1016/j.phymed.2022.154005
   PubMed Web of Science ®Google Scholar
• Durga DT, Babu M, Makinen P, et al. Aggravated postinfarct heart failure in type 2 diabetes is associated with impaired mitophagy and exaggerated inflammasome activation. Am J Pathol. 2017;187(12):2659–2673. doi:10.1016/j.ajpath.2017.08.023
   PubMedGoogle Scholar
• Cao LL, Guan PP, Zhang SQ, et al. Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice. J Neuroinflammation. 2021;18(1):281. doi:10.1186/s12974-021-02327-4
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yao Y, Qiu X, et al. Listeria hijacks host mitophagy through a novel mitophagy receptor to evade killing. Nat Immunol. 2019;20(4):433–446. doi:10.1038/s41590-019-0324-2
   PubMed Web of Science ®Google Scholar
• Li S, Zhou Y, Gu X, et al. NLRX1/FUNDC1/NIPSNAP1-2 axis regulates mitophagy and alleviates intestinal ischaemia/reperfusion injury. Cell Prolif. 2021;54(3):e12986. doi:10.1111/cpr.12986
   PubMed Web of Science ®Google Scholar